Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1

Interventions

pembrolizumab 4Magnetic Resonance Spectroscopy 4Radiotherapy 3Nivolumab 3Cetuximab 3fluoromisonidazole 2durvalumab 2Neoadjuvant Therapy 2Metformin 2Immunohistochemistry 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Cisplatin 2sitravatinib 1ruxolitinib 1ribociclib 1fluciclovine F-18 1dornase alfa 1avelumab 1antitumor A 1alovudine 1Varenicline 1Valproic Acid 1VTX-2337 1TAK-981 1Surgical Procedures, Operative 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Plastic Surgery Procedures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Squamous Cell Carcinoma of Head and Neck × CP protocol × Clear all
NCT06062602 2023-10-06

PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

Presage Biosciences

Phase EARLY_PHASE1 Completed
15 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡